PharmaMénta Aps: Financial statements 2012
CVR: 25615697
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
PharmaMénta Aps (CVR 25615697) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK -6,401 and a net result of DKK 286,184. Equity in the 2012 report amounted to DKK 3,998,310. The solvency ratio was 99.9%.
- Gross Profit
- DKK -6,401
- Profit/Loss
- DKK 286,184
- Equity
- DKK 3,998,310
- Total Assets
- DKK 4,003,309
Official annual report
Keep an eye on PharmaMénta Aps
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of December 21, 2012, Partner Revision statsautoriseret revisionsaktieselskab has been appointed auditor of PharmaMénta Aps.
As of December 21, 2012, Svend Erik Jespersen has stepped down as auditor of PharmaMénta Aps.
As of December 21, 2012, Tom Krongaard Thomsen has joined the board of directors of PharmaMénta Aps.
As of December 21, 2012, Lasse Hvingelby Kikkenborg has joined the board of directors of PharmaMénta Aps.
As of December 21, 2012, Jørgen Makholm has left the board of directors of PharmaMénta Aps.
As of December 21, 2012, Janus Hvingelby Kikkenborg has left the board of directors of PharmaMénta Aps.
About PharmaMénta Aps
PharmaMénta Aps is a Danish company of the type Anpartsselskab based in Esbjerg V, founded in 2000. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jimmi Javed Christensen Malik. The board consists of Lasse Hvingelby Kikkenborg (chair), Jimmi Javed Christensen Malik and Torben Hvingelby Pedersen. The company is owned by Torben Hvingelby Pedersen, LHK Holding Esbjerg ApS and JMINT Holding ApS. The company has 3 employees (2008). In 2025, the company reported a gross profit of DKK 5,249,012 and a net result of DKK 2,364,968 compared with DKK 2,121,363 the year before. Equity in the 2025 report amounted to DKK 5,130,022.